Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9322 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8723 |
High Similarity |
NPD7435 |
Discontinued |
0.8644 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD8313 |
Approved |
0.8611 |
High Similarity |
NPD8312 |
Approved |
0.8549 |
High Similarity |
NPD7874 |
Approved |
0.8549 |
High Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8478 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8453 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8453 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8429 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8429 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8429 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8402 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8398 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.837 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8351 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8297 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.829 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.829 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8287 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8263 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8232 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8223 |
Intermediate Similarity |
NPD7801 |
Approved |
0.8223 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8223 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8222 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8202 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8201 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8201 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8128 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8066 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8066 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8066 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7979 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7898 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.788 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7869 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7821 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7753 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7709 |
Intermediate Similarity |
NPD1934 |
Approved |
0.768 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.768 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.768 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7657 |
Intermediate Similarity |
NPD6799 |
Approved |
0.765 |
Intermediate Similarity |
NPD5494 |
Approved |
0.764 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7637 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7627 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7614 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7614 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7614 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7612 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD37 |
Approved |
0.7596 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7569 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7542 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7512 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7512 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7475 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7374 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7371 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7318 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD919 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7249 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7196 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7196 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7196 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7191 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7159 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7116 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7115 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7113 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7102 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7091 |
Intermediate Similarity |
NPD8067 |
Phase 3 |
0.7087 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7085 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7085 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7085 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7064 |
Intermediate Similarity |
NPD8491 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7062 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD920 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7016 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD6273 |
Approved |
0.6971 |
Remote Similarity |
NPD1240 |
Approved |
0.6954 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6954 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6944 |
Remote Similarity |
NPD1243 |
Approved |
0.694 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD1933 |
Approved |
0.6932 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6927 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6893 |
Remote Similarity |
NPD6651 |
Approved |
0.6878 |
Remote Similarity |
NPD8485 |
Approved |
0.6868 |
Remote Similarity |
NPD2309 |
Approved |
0.6866 |
Remote Similarity |
NPD4665 |
Approved |
0.6866 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6857 |
Remote Similarity |
NPD7985 |
Registered |
0.6857 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6856
|
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |